The MRC’s Experimental Medicine Grants meet the high cost of human in vivo research
- The bulk of the research—and costs—should relate to human in vivo experiments.
- There must be a central interventional element; this is not a scheme for observational studies.
- If you can substitute non-human studies for human ones then this is not the right scheme for your project.
- Good bids will investigate a defined knowledge gap.
- Industry partnerships are encouraged.
The Medical Research Council’s Experimental Medicine Grants open twice a year to support work that explores the causes, progression and treatment of human diseases. The work produced through these MRC grants will offer insights into human diseases to ultimately identify ways to stop or alter their progression.